Home » Topics » BioWorld

BioWorld
RSS

EPO LIMITED BENEFITS AS SURGERY ADJUNCT

March 31, 1992

NCI INITIATES TRIAL OF ONCOLYSIN B

March 31, 1992

FDA APPROVES CHIRON UNIT'S LENS

March 31, 1992

ENZON TO COLLABORATE WITH CYTOCLONAL

March 31, 1992

IMRE SPINS OFF A DIAGNOSTIC UNIT

March 31, 1992

GENSIA OPENS NEW ARASINE TRIALS

March 31, 1992

ANALYST PREDICTS 2Q REBOUND BY TOP STOCKS

March 31, 1992

GYNEX TECH EXCHANGE WITH BRISTOL-MYERS

March 31, 1992

ADVANCED TISSUE PROPOSES $21M ACQUISITION

March 31, 1992

CARBOHYDRATE COMPANY FILES IPO

March 30, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...